Tag: NCT02052778

Home / NCT02052778

Categories

Cccelerated approval is granted by FDA to futibatinib for cholangiocarcinoma

November 2022: The Food and Drug Administration granted accelerated approval to futibatinib (Lytgobi, Taiho Oncology, Inc.) for adult patients with previously treated, unresectable, locally advanced o...
nct02052778

Scan the code